Deutsch English Français

Contact

EP0209030

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP0209030

EP0209030 - Use of tumour necrosis factor in the preparation of pharmaceutical compounds [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 15.05.1990 Database last updated on 28.03.2026
Most recent event Tooltip	07.07.2007	Change - inventor	published on 08.08.2007 [2007/32]
Applicant(s)	For all designated states BASF Aktiengesellschaft Carl-Bosch-Strasse 38 67063 Ludwigshafen / DE
	[N/P]
Former [1987/04]	For all designated states BASF Aktiengesellschaft Carl-Bosch-Strasse 38 D-67063 Ludwigshafen / DE
Inventor(s)	01 / Kirchner, Holger, Prof. Dr. Kussmaulstrasse 3 D-6900 Heidelberg / DE
	02 / Jacobsen, Helmut, Dr. Kurpfalzstrasse 9 D-6905 Schriesheim / DE
	[1987/04]
Application number, filing date	86109208.8	05.07.1986
	[1987/04]
Priority number, date	DE19853525750	19.07.1985 Original published format: DE 3525750
	[1987/04]
Filing language	DE
Procedural language	DE
Publication	Type:	A2 Application without search report
	No.:	EP0209030
	Date:	21.01.1987
	Language:	DE
	[1987/04]
	Type:	A3 Search report
	No.:	EP0209030
	Date:	16.03.1988
	Language:	DE
	[1988/11]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	25.01.1988
Classification	IPC:	A61K37/02	[1987/04]
	CPC:	A61K38/191 (EP); A61P31/12 (EP); Y02A50/30 (EP)
Designated contracting states	AT, BE, CH, DE, FR, GB, IT, LI, NL, SE [1987/04]
Title	German:	Verwendung vom Tumornekrosefaktor zur Herstellung von Arzneimitteln	[1987/04]
	English:	Use of tumour necrosis factor in the preparation of pharmaceutical compounds	[1987/04]
	French:	Application du facteur de nécrose des tumeurs à la préparation de produits pharmaceutiques	[1987/04]
File destroyed:	18.06.1996
Examination procedure	06.02.1988	Examination requested [1988/14]
	24.08.1989	Despatch of a communication from the examining division (Time limit: M04)
	04.01.1990	Application deemed to be withdrawn, date of legal effect [1990/27]
	06.02.1990	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1990/27]
Fees paid	Renewal fee
	23.07.1988	Renewal fee patent year 03
	21.07.1989	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[AD] Nature, Vol. 312, 20.-27. Dezember 1984 PENNICA D. et al. "Human Tumour Necrosis Factor: Precursor, Structure, Expression and Homology to Lymphotoxin" seiten 724-729 * gesamt * [AD]

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.